TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Divi’s Laboratories Limited ( (IN:DIVISLAB) ) just unveiled an announcement.
Divi’s Laboratories Limited has announced the closure of its trading window starting October 1, 2025, in compliance with SEBI regulations to prevent insider trading. This closure will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter and half-year ending September 30, 2025. The decision underscores the company’s commitment to regulatory compliance and transparency in its financial reporting, which is crucial for maintaining investor trust and industry credibility.
More about Divi’s Laboratories Limited
Divi’s Laboratories Limited operates in the pharmaceutical industry, specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. The company is recognized for its focus on generic drug manufacturing and caters to a global market, providing essential components for various medications.
Average Trading Volume: 9,225
Technical Sentiment Signal: Buy
Current Market Cap: 1510.6B INR
See more insights into DIVISLAB stock on TipRanks’ Stock Analysis page.